News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
176,573 Results
Type
Article (8165)
Company Profile (38)
Press Release (168370)
Section
Business (55870)
Career Advice (167)
Deals (9976)
Drug Delivery (22)
Drug Development (13557)
Employer Resources (20)
FDA (4850)
Job Trends (4247)
News (84674)
Policy (6972)
Tag
Academia (754)
Alliances (18966)
Alzheimer's disease (559)
Antibody-drug conjugate (ADC) (42)
Approvals (4831)
Artificial intelligence (153)
Bankruptcy (57)
Best Places to Work (3683)
Breast cancer (96)
Cancer (712)
Career advice (148)
CAR-T (39)
Cell therapy (114)
Clinical research (10755)
Collaboration (399)
COVID-19 (789)
C-suite (63)
Data (434)
Diabetes (44)
Diagnostics (5933)
Drug discovery (47)
Earnings (18787)
Events (20444)
Executive appointments (212)
FDA (5201)
Funding (329)
Gene therapy (105)
GLP-1 (108)
Government (1193)
Healthcare (5030)
Infectious disease (833)
IPO (3694)
Job creations (706)
Job search strategy (133)
Layoffs (78)
Legal (749)
Lung cancer (94)
Lymphoma (62)
Manufacturing (102)
Medical device (3967)
Medtech (3970)
Mergers & acquisitions (6452)
Metabolic disorders (108)
Neuroscience (700)
NextGen: Class of 2025 (1428)
Non-profit (1369)
Northern California (644)
Obesity (51)
Opinion (55)
Parkinson's disease (42)
People (15327)
Phase I (3269)
Phase II (4598)
Phase III (4145)
Pipeline (284)
Postmarket research (336)
Preclinical (1230)
Press Release (40)
Radiopharmaceuticals (151)
Rare diseases (107)
Real estate (1564)
Regulatory (5617)
Research institute (879)
Series A (55)
Series B (39)
Southern California (491)
Startups (1273)
United States (5669)
Vaccines (130)
Date
Today (2)
Last 7 days (258)
Last 30 days (945)
Last 365 days (10790)
2025 (1980)
2024 (10714)
2023 (12104)
2022 (17120)
2021 (17797)
2020 (16223)
2019 (12104)
2018 (9047)
2017 (8944)
2016 (8469)
2015 (9309)
2014 (6624)
2013 (5642)
2012 (6123)
2011 (6283)
2010 (5412)
Location
Africa (187)
Arizona (58)
Asia (10425)
Australia (1825)
California (1410)
Canada (515)
China (113)
Colorado (74)
Connecticut (92)
Delaware (42)
Europe (25620)
Florida (207)
Georgia (46)
Illinois (156)
Indiana (79)
Maryland (198)
Massachusetts (978)
Michigan (91)
Minnesota (108)
New Jersey (329)
New York (551)
North Carolina (306)
Northern California (644)
Ohio (69)
Pennsylvania (262)
South America (244)
Southern California (491)
Texas (223)
Utah (86)
Virginia (49)
Washington State (117)
176,573 Results for "accelerate diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
January 13, 2025
·
8 min read
FDA
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
September 30, 2024
·
6 min read
Business
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024.
May 8, 2024
·
14 min read
Press Releases
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
November 8, 2024
·
17 min read
Deals
Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.
June 11, 2024
·
3 min read
Business
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results.
May 2, 2024
·
1 min read
Business
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
October 25, 2024
·
2 min read
Business
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.
March 28, 2024
·
19 min read
Deals
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Quest Diagnostics announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
May 1, 2024
·
7 min read
Accelerated approval
Inspector General Questions FDA’s Accelerated Approval for Biogen, Sarepta Drugs
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, Sarepta’s Exondys and Covis’ Makena.
January 15, 2025
·
2 min read
·
Tristan Manalac
1 of 17,658
Next
